Anogenital Distance (AGD) Framework
Measure of Fetal Androgen Exposure
The Anogenital Distance (AGD) Framework is a measure of fetal androgen exposure, which can be used to predict reproductive health outcomes in males and females. The framework involves measuring the distance between the anus and the genitals in newborns, which can indicate the level of androgen exposure during fetal development. Studies have shown that shorter AGD is associated with lower sperm count and reduced fertility in males, while longer AGD in females is associated with higher androgen exposure and potential reproductive health issues.
- Fetal androgen exposure can be measured through anogenital distance (AGD) in newborns.
- AGD is a predictor of reproductive health outcomes in males and females.
- Androgen exposure during fetal development can have long-term effects on reproductive health.
- Measure AGD in NewbornsMeasure the distance between the anus and the genitals in newborns to determine fetal androgen exposure.Pro tipUse a standardized measurement technique to ensure accuracy.WarningMeasurements should only be taken by trained healthcare professionals.
- Interpret AGD ResultsInterpret AGD results in the context of reproductive health outcomes, taking into account potential correlations with sperm count and fertility.Pro tipConsider multiple factors, including AGD, when assessing reproductive health.WarningAGD results should not be used as the sole indicator of reproductive health.
A study found a correlation between shorter AGD and lower sperm count in males, highlighting the potential predictive value of AGD for reproductive health outcomes.
The AGD Framework was developed through studies on animal models and human populations, which demonstrated a correlation between AGD and fetal androgen exposure. The framework has been refined through subsequent studies, including those conducted by Dr. Shanna Swan and her colleagues.